Viewing Study NCT00577694


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-03-12 @ 12:41 AM
Study NCT ID: NCT00577694
Status: TERMINATED
Last Update Posted: 2015-10-12
First Post: 2007-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult acute myeloid leukemia View